
Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs
Author(s) -
Furio Pirozzi Farina,
A. Pischedda
Publication year - 2016
Publication title -
archivio italiano di urologia andrologia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.429
H-Index - 23
eISSN - 2282-4197
pISSN - 1124-3562
DOI - 10.4081/aiua.2015.4.312
Subject(s) - cover (algebra) , subject (documents) , adverse effect , order (exchange) , psychology , medicine , computer science , engineering , pharmacology , world wide web , business , mechanical engineering , finance
Treatment-induced sexual dysfunctions (SD) are a recurrent and controversial topic in recent literature on the adverse events related to the use of 5-alpha-reductase inhibitors (5ARIs) (1, 2). In order to deal adequately with the various aspects of this topic, it is necessary to first cover some of the steps that allow a better definition and understanding of the subject.